Cocrystal Pharma
COCP
#10253
Rank
A$20.63 M
Marketcap
A$1.50
Share price
-1.00%
Change (1 day)
-55.77%
Change (1 year)

Earnings for Cocrystal Pharma (COCP)

Earnings in 2025 (TTM): -A$15.31 Million

According to Cocrystal Pharma 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$27.03 Million, an increase over its 2023 earnings that were of -A$32 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cocrystal Pharma from 2008 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$15.31 Million-43.37%
2024 -A$27.03 Million-15.51%
2023 -A$32 Million16.66%
2022 -A$27.43 Million27.9%
2021 -A$21.45 Million47.11%
2020 -A$14.58 Million-79.98%
2019 -A$72.8 Million-22.92%
2018 -A$94.45 Million651.62%
2017 -A$12.57 Million-92.14%
2016 -A$0.16 Billion96.12%
2015 -A$81.57 Million830.46%
2014 -A$8.77 Million18.04%
2013 -A$7.43 Million95.95%
2012 -A$3.8 Million-31.98%
2011 -A$5.58 Million
2009 -A$0.07 Million-23.29%
2008 -A$0.09 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Merck
MRK
A$34.90 B-236,484.11%๐Ÿ‡บ๐Ÿ‡ธ USA
USANA
USNA
A$73.51 M-597.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$48.97 B-331,754.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Nature's Sunshine Products
NATR
A$41.46 M-380.74%๐Ÿ‡บ๐Ÿ‡ธ USA